Literature DB >> 18685195

Inhibition of thioredoxin reductase by curcumin analogs.

Zhong Liu1, Zhi-Yun Du, Zhi-Shu Huang, Kin-Sing Lee, Lian-Quan Gu.   

Abstract

Curcumin analogs were first investigated for their inhibitory effects on thioredoxin reductase (TrxR). Most of them were more potent TrxR inhibitors than natural curcumin. The structure-activity relationship was summarized, and the curcumin analog was found to inhibit TrxR irreversibly in a time-dependent manner. The action was caused by covalent modification of the redox-active residues Cys(497) and Sec(498) in TrxR.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18685195     DOI: 10.1271/bbb.80229

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  6 in total

Review 1.  Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?

Authors:  Jayaraj Ravindran; Sahdeo Prasad; Bharat B Aggarwal
Journal:  AAPS J       Date:  2009-07-10       Impact factor: 4.009

Review 2.  Redox-directed cancer therapeutics: molecular mechanisms and opportunities.

Authors:  Georg T Wondrak
Journal:  Antioxid Redox Signal       Date:  2009-12       Impact factor: 8.401

3.  Effects of Mammalian Thioredoxin Reductase Inhibitors.

Authors:  Elias S J Arnér
Journal:  Handb Exp Pharmacol       Date:  2021

4.  (3E,5E)-3,5-Bis(4-hy-droxy-3,5-di-methoxy-benzyl-idene)oxan-4-one monohydrate.

Authors:  Zhi-Yun Du; Hua-Rong Huang; Yu-Jun Lu; Kun Zhang; Yan-Xiong Fang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-11-27

5.  B5, a thioredoxin reductase inhibitor, induces apoptosis in human cervical cancer cells by suppressing the thioredoxin system, disrupting mitochondrion-dependent pathways and triggering autophagy.

Authors:  Fang-Yuan Shao; Zhi-Yun Du; Dong-Lei Ma; Wen-Bo Chen; Wu-Yu Fu; Bi-Bo Ruan; Wen Rui; Jia-Xuan Zhang; Sheng Wang; Nai Sum Wong; Hao Xiao; Man-Mei Li; Xiao Liu; Qiu-Ying Liu; Xiao-Dong Zhou; Hai-Zhao Yan; Yi-Fei Wang; Chang-Yan Chen; Zhong Liu; Hong-Yuan Chen
Journal:  Oncotarget       Date:  2015-10-13

Review 6.  Thioredoxin reductase: An emerging pharmacologic target for radiosensitization of cancer.

Authors:  Raghavendra S Patwardhan; Deepak Sharma; Santosh K Sandur
Journal:  Transl Oncol       Date:  2022-01-23       Impact factor: 4.243

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.